688506 百利天恒
已收盘 04-10 15:00:01
资讯
新帖
简况
百利天恒拟募资39亿元押注创新药，“深蹲”中等待强势“起跳”
Ofweek维科网 · 03-11
百利天恒拟募资39亿元押注创新药，“深蹲”中等待强势“起跳”
百利天恒拟募资39亿元，加大创新药研发
医药魔方 · 03-11
百利天恒拟募资39亿元，加大创新药研发
一家创新药企融资的“双线作战”
信风TradeWind · 03-10
一家创新药企融资的“双线作战”
新事 | 百利天恒拟再融资39亿，投向ADC
健识局 · 03-10
新事 | 百利天恒拟再融资39亿，投向ADC
H股IPO刚二次递表，800亿市值创新药“新贵”百利天恒又抛39亿A股定增案
钛媒体 · 03-10
H股IPO刚二次递表，800亿市值创新药“新贵”百利天恒又抛39亿A股定增案
继冲刺港股IPO后，成都创新药龙头拟39亿元再融资
红星新闻 · 03-10
继冲刺港股IPO后，成都创新药龙头拟39亿元再融资
百利天恒拟募资39亿押注创新药，BMS首付款驱动扭亏
财中社 · 03-10
百利天恒拟募资39亿押注创新药，BMS首付款驱动扭亏
去年赚了近37亿元，港股上市推进中 百利天恒又推39亿元定增计划
每日经济新闻 · 03-10
去年赚了近37亿元，港股上市推进中 百利天恒又推39亿元定增计划
筹划赴港上市后又有大动作！百利天恒拟定增募资不超39亿加码创新药
北京商报 · 03-09
筹划赴港上市后又有大动作！百利天恒拟定增募资不超39亿加码创新药
百利天恒将于3月25日召开股东大会，审议公司前次募集资金使用情况报告等议案
金融界 · 03-09
百利天恒将于3月25日召开股东大会，审议公司前次募集资金使用情况报告等议案
百利天恒(688506.SH)拟定增募资不超39亿元用于创新药研发项目
智通财经 · 03-09
百利天恒(688506.SH)拟定增募资不超39亿元用于创新药研发项目
百利天恒公告称，公司拟向特定对象发行股票募资不超过39亿元，扣除发行费用后将全部用于创新药研发项目。
美港电讯 · 03-09
百利天恒公告称，公司拟向特定对象发行股票募资不超过39亿元，扣除发行费用后将全部用于创新药研发项目。
百利天恒：制定未来三年股东分红回报规划
每日经济新闻 · 03-09
百利天恒：制定未来三年股东分红回报规划
【百利天恒：拟定增募资不超39亿元 用于创新药研发项目】百利天恒公告，公司拟向特定对象发行股票募资不超过39亿元，扣除发行费用后将全部用于创新药研发项目。
金融界 · 03-09
【百利天恒：拟定增募资不超39亿元 用于创新药研发项目】百利天恒公告，公司拟向特定对象发行股票募资不超过39亿元，扣除发行费用后将全部用于创新药研发项目。
百利天恒(688506.SH)：拟定增募资不超39亿元
格隆汇 · 03-09
百利天恒(688506.SH)：拟定增募资不超39亿元
百利天恒在成都新设生物科技公司
企查查 · 03-06
百利天恒在成都新设生物科技公司
加载更多
公司概况
公司名称：
四川百利天恒药业股份有限公司
所属行业：
医药制造业
上市日期：
2023-01-06
主营业务：
四川百利天恒药业股份有限公司的主营业务是医药研发、制造及销售。公司的主要产品是丙泊酚乳状注射液、丙泊酚中/长链脂肪乳注射液、吸入用七氟烷、中/长链脂肪乳注射液、结构脂肪乳注射液(C6~24)、黄芪颗粒、盐酸胍法辛缓释片。
发行价格：
24.70
{"stockData":{"symbol":"688506","market":"SH","secType":"STK","nameCN":"百利天恒","latestPrice":240.54,"timestamp":1744268401000,"preClose":229.09,"halted":0,"volume":1397780,"delay":0,"changeRate":0.05,"floatShares":92070400,"shares":401000000,"eps":20.4377,"marketStatus":"已收盘","change":11.45,"latestTime":"04-10 15:00:01","open":240,"high":247,"low":230.92,"amount":336000000,"amplitude":0.0702,"askPrice":240.81,"askSize":3,"bidPrice":240.54,"bidSize":142,"shortable":0,"etf":0,"ttmEps":20.4377,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744335000000},"marketStatusCode":5,"adr":0,"adjPreClose":229.09,"symbolType":"stock_kcb","openAndCloseTimeList":[[1744248600000,1744255800000],[1744261200000,1744268400000]],"highLimit":252,"lowLimit":206.18,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":401000000,"isCdr":false,"pbRate":24.82,"roa":"--","peRate":11.769426,"roe":"184.86%","epsLYR":9.25,"committee":0.841808,"marketValue":96457000000,"turnoverRate":0.0152,"status":0,"afterMarket":{"amount":0,"volume":0,"close":240.54,"buyVolume":0,"sellVolume":0,"time":1744270438029,"indexStatus":"已收盘 04-10 15:30:00","preClose":229.09},"floatMarketCap":22147000000},"requestUrl":"/m/hq/s/688506","defaultTab":"news","newsList":[{"id":"2518672765","title":"百利天恒拟募资39亿元押注创新药，“深蹲”中等待强势“起跳”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518672765","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518672765?lang=zh_cn&edition=full","pubTime":"2025-03-11 14:22","pubTimestamp":1741674128,"startTime":"0","endTime":"0","summary":"来源｜医药研究社百利天恒这匹创新药“黑马”还在狂奔。具体而言，目前百利天恒的业务经营尚未展现出明显的可持续增长性。仿制药困境之下，百利天恒更加专注创新药布局。据财报，2021-2023年以及2024年前三季度，百利天恒研发费用分别约为2.79亿元、3.75亿元、7.46亿元、9.32亿元。百利天恒三季报显示，截至2024年9月30日，公司总负债为27.18亿元，较去年同期增长173.31%，其中应付账款2.83亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031114230698a36c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031114230698a36c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239","159992"],"gpt_icon":0},{"id":"2518754947","title":"百利天恒拟募资39亿元，加大创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2518754947","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518754947?lang=zh_cn&edition=full","pubTime":"2025-03-11 12:06","pubTimestamp":1741665997,"startTime":"0","endTime":"0","summary":"近日，四川百利天恒药业股份有限公司发布公告表示，拟向特定对象发行A股股票并募集资金不超过390,000.00万元(含本数)。扣除发行费用后，实际募集资金将全部用于创新药研发项目。预计2024年度，百利天恒实现营业收入为580,000.00万元左右，与上年同期相比将增加523,812.93万元左右，同比增加932.27%左右；扣除非经常性损益的净利润为355,500.00万元左右，与上年同期相比将增加436,774.87万元左右。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311121508abf53602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311121508abf53602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239","159992"],"gpt_icon":0},{"id":"2518120362","title":"一家创新药企融资的“双线作战”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518120362","media":"信风TradeWind","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518120362?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:05","pubTimestamp":1741619139,"startTime":"0","endTime":"0","summary":"百利天恒的再融资亦具有风向标的意义——A股创新药企的再融资闸口是否有望打开，正受到期待。正因如此，部分深陷亏损泥潭的A股创新药企选择通过港股IPO进行融资“补血”。这笔交易的潜在总交易额最高达84亿美元，刷新了中国创新药出海的纪录，是迄今为止全球 ADC 领域单个资产总交易额最大的全球战略许可交易。除此之外，还有合计13款创新药正在推进临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311012422a26a7b22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311012422a26a7b22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239","159992"],"gpt_icon":0},{"id":"2518275754","title":"新事 | 百利天恒拟再融资39亿，投向ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275754","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518275754?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:14","pubTimestamp":1741616056,"startTime":"0","endTime":"0","summary":"3月9日，百利天恒发布公告，计划向特定对象发行股票不超2005万股，并筹集资金不超39亿元。对于此次募集资金的用途，百利天恒表示将全部用于创新药研发项目，重点投向ADC、创新药多抗、核药三大创新药研发平台。三季报显示，百利天恒账上还有现金49.76亿元。同时据业绩快报显示，2024年百利天恒总收入58.23亿元，同比增长936.32%；净利润36.58亿元，同比扭亏为盈。此次，百利天恒抛出定增计划或许是希望抓住难得的再融资机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222508abf3105b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222508abf3105b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["162717","BK0239","688506"],"gpt_icon":0},{"id":"2518226917","title":"H股IPO刚二次递表，800亿市值创新药“新贵”百利天恒又抛39亿A股定增案","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226917","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518226917?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:45","pubTimestamp":1741610716,"startTime":"0","endTime":"0","summary":"A股上市两年，800亿市值创新药“新贵”百利天恒-U抛出再融资计划。3月10日，百利天恒公告称，公司拟向特定对象发行A股股票并募集资金不超过39亿元（含本数），扣除发行费用后，将全部用于创新药研发项目。但截至2024年9月末，该募资已累计使用7.66亿元，所剩无几。2024年5月，百利天恒即启动港股IPO，并于7月首次递表。今年1月21日，百利天恒二次递表。2024年，公司收到8亿美元不可撤销的首付款。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10204548634912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06978","BK1574","BK1161","399300","688506","159992","159982","BK0239"],"gpt_icon":0},{"id":"2518694402","title":"继冲刺港股IPO后，成都创新药龙头拟39亿元再融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2518694402","media":"红星新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518694402?lang=zh_cn&edition=full","pubTime":"2025-03-10 12:31","pubTimestamp":1741581060,"startTime":"0","endTime":"0","summary":"微成都报道继筹划赴港上市后，成都科创板上市企业百利天恒又有大动作。3月9日晚间，百利天恒发布定增预案，拟向特定对象发行不超过2005万股，募集资金总额不超过39亿元。公告显示，此次募集资金将全部用于创新药研发项目。资料显示，百利天恒是一家创新药企业，公司业务着重在肿瘤用药领域。随后今年1月21日，百利天恒重新向香港联交所递交H股发行上市申请，同时刊发申请资料。三季报显示，该公司账上货币资金达49.76亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031012320298a2191c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031012320298a2191c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","162717","BK0239","159992"],"gpt_icon":0},{"id":"2518269423","title":"百利天恒拟募资39亿押注创新药，BMS首付款驱动扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2518269423","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518269423?lang=zh_cn&edition=full","pubTime":"2025-03-10 12:24","pubTimestamp":1741580640,"startTime":"0","endTime":"0","summary":"百利天恒3月9日披露2025年度定增预案，拟募集资金不超过39亿元，全部投向创新药研发项目。此次发行方案已通过董事会审议，尚需股东大会及监管部门批准。本次预案允许募资到位前自有资金先行投入，或加剧现金流压力。本次发行决议有效期12个月，最终发行方案待上交所审核及证监会注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031012251998a217da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031012251998a217da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688506","159992"],"gpt_icon":0},{"id":"2518265028","title":"去年赚了近37亿元，港股上市推进中 百利天恒又推39亿元定增计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2518265028","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518265028?lang=zh_cn&edition=full","pubTime":"2025-03-10 12:10","pubTimestamp":1741579800,"startTime":"0","endTime":"0","summary":" 3月9日，百利天恒公告定增募资计划。 据公告，百利天恒计划向不超过35名特定投资者发行不超过2005万股（含本数），募集资金总额不超过39亿元（含本数），扣除发行费用后，实际募集资金将全部用于创新药研发项目。 在融资多路并行的背景下，市场给予了百利天恒信心。3月10日早盘，百利天恒一度上涨超2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-03-10/doc-inepcwtt3742811.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-10/doc-inepcwtt3742811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSCEI","688506","HSTECH","BK0239","YANG","07226","BK4614"],"gpt_icon":0},{"id":"2518924401","title":"筹划赴港上市后又有大动作！百利天恒拟定增募资不超39亿加码创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2518924401","media":"北京商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518924401?lang=zh_cn&edition=full","pubTime":"2025-03-09 18:11","pubTimestamp":1741515092,"startTime":"0","endTime":"0","summary":"继筹划赴港上市后，百利天恒又有大动作。随后今年1月21日，百利天恒重新向香港联交所递交H股发行上市申请，同时刊发申请资料。赴港上市、定增募资，或许透露出百利天恒目前急迫的融资需求。拟大手笔募资背后，百利天恒研发费用逐年增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030918113798a168cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030918113798a168cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239","159992"],"gpt_icon":0},{"id":"2518405308","title":"百利天恒将于3月25日召开股东大会，审议公司前次募集资金使用情况报告等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2518405308","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518405308?lang=zh_cn&edition=full","pubTime":"2025-03-09 16:00","pubTimestamp":1741507234,"startTime":"0","endTime":"0","summary":"金融界3月9日消息，百利天恒发布公告，将于2025年3月25日召开第1次临时股东大会，网络投票同日进行。股权登记日为3月18日，当日收市后持有百利天恒股票的投资者可以参与投票。会议地点：成都市高新区高新国际广场B座10楼会议室。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/09160048614735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688506"],"gpt_icon":0},{"id":"2518177403","title":"百利天恒(688506.SH)拟定增募资不超39亿元用于创新药研发项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2518177403","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518177403?lang=zh_cn&edition=full","pubTime":"2025-03-09 15:55","pubTimestamp":1741506942,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)发布2025年度向特定对象发行A股股票预案，公司本次发行的发行对象为不超过35名(含35名)符合法律法规规定的特定投资者，本次发行的股票数量按照募集资金总额除以发行价格确定，同时本次发行的股票数量不超过本次发行前公司总股本(截至2025年3月9日)的5%，即本次发行的股票数量不超过2005万股(含)，本次向特定对象发行股票募集资金总额不超过39亿元(含)，扣除发行费用后将用于创新药研发项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","688506","159992","BK1161","BK1574","BK0239"],"gpt_icon":0},{"id":"2518403650","title":"百利天恒公告称，公司拟向特定对象发行股票募资不超过39亿元，扣除发行费用后将全部用于创新药研发项目。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518403650","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518403650?lang=zh_cn&edition=full","pubTime":"2025-03-09 15:49","pubTimestamp":1741506554,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159992","688506","BK1574","BK1161","06978","BK0239"],"gpt_icon":0},{"id":"2518036574","title":"百利天恒：制定未来三年股东分红回报规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2518036574","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518036574?lang=zh_cn&edition=full","pubTime":"2025-03-09 15:46","pubTimestamp":1741506374,"startTime":"0","endTime":"0","summary":"每经AI快讯，百利天恒3月9日晚间发布公告称，公司董事会制定了《四川百利天恒药业股份有限公司未来三年股东分红回报规划》。公司原则上最近3年以现金方式累计分配的利润不少于最近3年公司实现的年均可分配利润的30%，每年以现金方式分配的利润不少于公司当年实现的可分配利润10%。百利天恒的总经理、董事长均是朱义，男，61岁，学历背景为博士。每经头条（nbdtoutiao）——专访全国政协常委、经济委员会副主任冯正霖：平台经济要在发展中规范 在规范中发展(记者 王晓波)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309154702963ee77e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309154702963ee77e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688506"],"gpt_icon":0},{"id":"2518596403","title":"【百利天恒：拟定增募资不超39亿元 用于创新药研发项目】百利天恒公告，公司拟向特定对象发行股票募资不超过39亿元，扣除发行费用后将全部用于创新药研发项目。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518596403","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518596403?lang=zh_cn&edition=full","pubTime":"2025-03-09 15:45","pubTimestamp":1741506323,"startTime":"0","endTime":"0","summary":"百利天恒公告，公司拟向特定对象发行股票募资不超过39亿元，扣除发行费用后将全部用于创新药研发项目。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/09154548614657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK1574","159992","06978","688506","BK1161"],"gpt_icon":0},{"id":"2518403519","title":"百利天恒(688506.SH)：拟定增募资不超39亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518403519","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518403519?lang=zh_cn&edition=full","pubTime":"2025-03-09 15:37","pubTimestamp":1741505871,"startTime":"0","endTime":"0","summary":"格隆汇3月9日丨百利天恒(688506.SH)公布2025年度向特定对象发行A股股票预案，本次向特定对象发行股票募集资金总额不超过39亿元（含本数），扣除发行费用后将用于创新药研发项目。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/09153748614589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688506","BK0239"],"gpt_icon":0},{"id":"2517184054","title":"百利天恒在成都新设生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2517184054","media":"企查查","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517184054?lang=zh_cn&edition=full","pubTime":"2025-03-06 15:40","pubTimestamp":1741246806,"startTime":"0","endTime":"0","summary":"企查查APP显示，近日，成都诺芯生物科技有限公司成立，法定代表人为朱义，注册资本300万元，经营范围包含：技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；技术进出口；货物进出口。企查查股权穿透显示，该公司由百利天恒（688506）全资持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306154115989e4148&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306154115989e4148&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159837","BK0239","688506"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1744301675341,"stockEarnings":[{"period":"1week","weight":-0.0725},{"period":"1month","weight":0.0753},{"period":"3month","weight":0.1888},{"period":"6month","weight":0.2121},{"period":"1year","weight":0.7714},{"period":"ytd","weight":0.1949}],"compareEarnings":[{"period":"1week","weight":-0.0487},{"period":"1month","weight":-0.0533},{"period":"3month","weight":-0.0077},{"period":"6month","weight":-0.0096},{"period":"1year","weight":0.0454},{"period":"ytd","weight":-0.0492}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川百利天恒药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4637人(较上一季度减少5.77%)","perCapita":"19855股","listingDate":"2023-01-06","address":"四川省成都市温江区成都海峡两岸科技产业园百利路161号一幢一号","registeredCapital":"40100万元","survey":" 四川百利天恒药业股份有限公司的主营业务是医药研发、制造及销售。公司的主要产品是丙泊酚乳状注射液、丙泊酚中/长链脂肪乳注射液、吸入用七氟烷、中/长链脂肪乳注射液、结构脂肪乳注射液(C6~24)、黄芪颗粒、盐酸胍法辛缓释片。","listedPrice":24.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百利天恒(688506)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百利天恒(688506)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百利天恒,688506,百利天恒股票,百利天恒股票老虎,百利天恒股票老虎国际,百利天恒行情,百利天恒股票行情,百利天恒股价,百利天恒股市,百利天恒股票价格,百利天恒股票交易,百利天恒股票购买,百利天恒股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百利天恒(688506)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百利天恒(688506)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}